Clinical Trial of L-Grb-2 Antisense Oligonucleotide in CML, AML, ALL & MDS

The recruitment status of this study is unknown because the information has not been verified recently.
Verified April 2010 by Bio-Path Holdings, Inc..
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Bio-Path Holdings, Inc.
ClinicalTrials.gov Identifier:
NCT01159028
First received: July 7, 2010
Last updated: July 8, 2010
Last verified: April 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given